Search results
Results from the WOW.Com Content Network
Varenicline is indicated for use as an aid to smoking cessation treatment [5] and for the treatment of the signs and symptoms of dry eye disease. [6] Varenicline is used to help people stop smoking tobacco (smoking cessation). A meta-analysis found that 20% of people treated with varenicline remain abstinent from smoking at one year. [15]
There are few interactions between nicotine and prescription medications (e.g., adenosine, cimetidine, varenicline), but the act of quitting smoking can impact the effect of other medications. [4] Some of the medications are: [5] Antipsychotic medications; Heart-related medications; Caffeine
Nicotine replacement therapy is as effective as medications, such as bupropion, in helping people quit smoking for at least six months. [16] All forms of nicotine replacement therapy, including nicotine gum, patches, nasal spray, inhalers, and lozenges, have similar success rates in terms of helping people stop smoking.
These medications include bupropion and nortriptyline. [25] Bupropion inhibits the re-uptake of nor-epinephrine and dopamine and has been FDA approved for smoking cessation, while nortriptyline is a tricyclic antidepressant which has been used to aid in smoking cessation it has not been FDA approved for this indication. [25]
Smoking cessation, usually called quitting smoking or stopping smoking, is the process of discontinuing tobacco smoking. [1] Tobacco smoke contains nicotine , which is addictive and can cause dependence .
The first study of the pharmacokinetics of a transdermal nicotine patch in humans was published in 1984 [3] by Jed Rose, Murray Jarvik, and Daniel Rose, and was followed by publication by Rose et al. (1985) of results of a study of smokers showing that a transdermal nicotine patch reduced craving for cigarettes. [4]
Drugs that influence nAChRs can be agonists, partial agonists or antagonists. [1] Agonists, e.g. nicotine, can however act as depolarizing agents when encountered to nAChRs for some time (seconds or minutes, depending on concentration and nAChR subtype), chronic exposure to agonist can also lead to long lasting functional deactivation because ...
Nicotine gum is a chewing gum containing a small dose of nicotine polacrilex. [1] It is classified as a short-acting (also called fast-acting) form of NRT because it relieves the cravings and symptoms that occur with smoking cessation more quickly than a long-acting NRT (i.e., the nicotine patch).